Review: taking Atenolol and Multaq together


Summary

Drug interactions are reported among people who take Atenolol and Multaq together. This review analyzes the effectiveness and drug interactions between Atenolol and Multaq. It is created by eHealthMe based on reports of 198 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Atenolol and Multaq >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Atenolol

Atenolol has active ingredients of atenolol. It is often used in high blood pressure. (latest outcomes from Atenolol 82,266 users)

Multaq

Multaq has active ingredients of dronedarone hydrochloride. It is often used in atrial fibrillation/flutter. (latest outcomes from Multaq 4,863 users)

On Jul, 24, 2016

198 people who take Atenolol, Multaq are studied.


Number of reports submitted per year:

Atenolol and Multaq drug interactions.

Drug effectiveness over time:

Atenolol:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 66.0% - (2 of 3 people)
  • not specified: 0.0% - (0 of 0 people)
Multaq:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Atenolol:
  • female: 50.0% - (2 of 4 people)
  • male: 0.0% - (0 of 0 people)
Multaq:
  • female: 66.0% - (2 of 3 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Atenolol:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 50.0% - (2 of 4 people)
Multaq:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 66.0% - (2 of 3 people)

Most common drug interactions over time *:

< 1 month:
  • dyspnoea
  • acute respiratory failure
  • cardiac failure congestive
  • interstitial lung disease
  • cardiac failure
  • abasia
  • fall
  • hand fracture
  • muscular weakness
  • atrial fibrillation
1 - 6 months:
  • atrial fibrillation
  • dyspnoea
  • weight decreased
  • cardiac failure
  • cardiac failure congestive
  • fatigue
  • oedema peripheral
  • blood creatinine increased
  • blood urea increased
  • brain natriuretic peptide increased
6 - 12 months:
  • atrial fibrillation
  • cough
  • dyspnoea
  • blood creatinine increased
  • blood urea increased
  • chest discomfort
  • pleural effusion
  • pulmonary function test abnormal
  • alanine aminotransferase increased
  • anxiety
1 - 2 years:
  • cough
  • dyspepsia
  • dyspnoea
  • hypoxia
  • interstitial lung disease
  • rales
2 - 5 years:
  • bone and joint pain
  • stiffness in a joint
5 - 10 years:
  • asthenia
  • atrial fibrillation
  • chest discomfort
  • dyspnoea
  • fatigue
  • gait disturbance
  • heart rate increased
  • non-cardiac chest pain
  • weight fluctuation
  • wheezing
10+ years:
  • fatigue
  • obesity
  • obstructive sleep apnea syndrome
  • orthostatic hypotension
  • shortness of breath
  • spinocerebellar ataxia
  • weakness
  • renal failure chronic
  • sinoatrial block
  • bone and joint pain
not specified:
  • atrial fibrillation
  • dyspnoea
  • fatigue
  • cardiac failure
  • asthenia
  • oedema peripheral
  • cardiac failure congestive
  • nausea
  • diarrhoea
  • blood creatinine increased

Most common drug interactions by gender *:

female:
  • atrial fibrillation
  • dyspnoea
  • cardiac failure congestive
  • muscle spasms
  • oedema peripheral
  • fatigue
  • nausea
  • asthenia
  • brain natriuretic peptide increased
  • cardiac failure
male:
  • fatigue
  • dyspnoea
  • atrial fibrillation
  • cardiac failure
  • oedema peripheral
  • blood creatinine increased
  • asthenia
  • blood urea increased
  • cardiac failure congestive
  • diarrhoea

Most common drug interactions by age *:

40-49:
  • cardiac arrest
50-59:
  • blood creatinine increased
  • blood urea increased
  • fatigue
  • pain
  • dyspnoea
  • muscle spasms
  • renal impairment
  • atrial fibrillation
  • abasia
  • abdominal pain
60+:
  • atrial fibrillation
  • dyspnoea
  • cardiac failure
  • asthenia
  • cardiac failure congestive
  • fatigue
  • oedema peripheral
  • nausea
  • palpitations
  • diarrhoea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Atenolol and Multaq?

Can you answer these questions?

More questions for: Atenolol, Multaq

You may be interested in these reviews

More reviews for: Atenolol, Multaq

On eHealthMe, Atenolol (atenolol) is often used to treat high blood pressure. Multaq (dronedarone hydrochloride) is often used to treat atrial fibrillation/flutter. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.